Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 8
Submit an article Journal homepage
606
Views
144
CrossRef citations to date
0
Altmetric
Review

Grb2 signaling in cell motility and cancer

Alessio Giubellino National Cancer Institute, Urologic Oncology Branch, CCR, Building 10 CRC 1 West Room 3961, 10 Center Drive MSC 1107, Bethesda, MD 20892-1107, USA +1 301 594 7953; +1 301 402 0922; [email protected]
,
Jr Terrence R Burke National Cancer Institute, Laboratory of Medicinal Chemistry, Frederick, Maryland, USA
&
Donald P Bottaro National Cancer Institute, Urologic Oncology Branch, CCR, Building 10 CRC 1 West Room 3961, 10 Center Drive MSC 1107, Bethesda, MD 20892-1107, USA +1 301 594 7953; +1 301 402 0922; [email protected]
Pages 1021-1033 | Published online: 12 Jul 2008

Bibliography

  • Christofori G. New signals from the invasive front. Nature 2006;441(7092):444-50
  • Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 2003;3(6):453-8
  • Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12(8):895-904
  • Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411(6835):355-65
  • Pawson T. Dynamic control of signaling by modular adaptor proteins. Curr Opin Cell Biol 2007;19(2):112-6
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57-70
  • Downward J. The GRB2/Sem-5 adaptor protein. FEBS Lett 1994;338(2):113-7
  • Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992;70(3):431-42
  • Dharmawardana PG, Peruzzi B, Giubellino A, et al. Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs 2006;17(1):13-20
  • Tari AM, Lopez-Berestein G. GRB2: a pivotal protein in signal transduction. Semin Oncol 2001;28(5 Suppl 16):142-7
  • Cheng AM, Saxton TM, Sakai R, et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 1998;95(6):793-803
  • Saxton TM, Cheng AM, Ong SH, et al. Gene dosage-dependent functions for phosphotyrosine-Grb2 signaling during mammalian tissue morphogenesis. Curr Biol 2001;11(9):662-70
  • Huebner K, Kastury K, Druck T, et al. Chromosome locations of genes encoding human signal transduction adapter proteins, Nck (NCK), Shc (SHC1), and Grb2 (GRB2). Genomics 1994;22(2):281-7
  • Pendergast AM, Quilliam LA, Cripe LD, et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993;75(1):175-85
  • Daly RJ, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 1994;9(9):2723-7
  • Verbeek BS, driaansen-Slot SS, Rijksen G, Vroom TM. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol 1997;183(2):195-203
  • Zang XP, Siwak DR, Nguyen TX, et al. KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exp Metastasis 2004;21(5):437-43
  • Watanabe T, Shinohara N, Moriya K, et al. Significance of the Grb2 and son of sevenless (SOS) proteins in human bladder cancer cell lines. IUBMB Life 2000;49(4):317-20
  • Misra UK, Pizzo SV. Potentiation of signal transduction mitogenesis and cellular proliferation upon binding of receptor-recognized forms of α2-macroglobulin to 1-LN prostate cancer cells. Cell Signal 2004;16(4):487-96
  • Gay B, Suarez S, Weber C, et al. Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility. J Biol Chem 1999;274(33):23311-5
  • Atabey N, Gao Y, Yao ZJ, et al. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem 2001;276(17):14308-14
  • Giubellino A, Gao Y, Lee S, et al. Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. Cancer Res 2007;67(13):6012-6
  • Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004;4(2):118-32
  • Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005;6(1):56-68
  • Cox BD, Natarajan M, Stettner MR, Gladson CL. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 2006;99(1):36-52
  • McLean GW, Carragher NO, Avizienyte E, et al. The role of focal-adhesion kinase in cancer: a new therapeutic opportunity. Nat Rev Cancer 2005;5(7):505-15
  • Schlaepfer DD, Hanks SK, Hunter T, Van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372(6508):786-91
  • Avizienyte E, Wyke AW, Jones RJ, et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002;4(8):632-8
  • Hazan RB, Qiao R, Keren R, et al. Cadherin switch in tumor progression. Ann NY Acad Sci 2004;1014:155-63
  • Suyama K, Shapiro I, Guttman M, Hazan RB. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002;2(4):301-14
  • Miyamoto S, Teramoto H, Coso OA, et al. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131(3):791-805
  • Schlaepfer DD, Jones KC, Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events? Mol Cell Biol 1998;18(5):2571-85
  • Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006;11(2 P.1591-2006):1696-701
  • Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007;26(3-4):717-24
  • Moss ML, Lambert MH. Shedding of membrane proteins by ADAM family proteases. Essays Biochem 2002;38:141-53
  • Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6(1):32-43
  • Suzuki A, Kadota N, Hara T, et al. Meltrin α cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene 2000;19(51):5842-50
  • Poghosyan Z, Robbins SM, Houslay MD, et al. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. J Biol Chem 2002;277(7):4999-5007
  • Zhou BB, Fridman JS, Liu X, et al. ADAM proteases, ErbB pathways and cancer. Expert Opin Investig Drugs 2005;14(6):591-606
  • Fridman JS, Caulder E, Hansbury M, et al. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin Cancer Res 2007;13(6):1892-902
  • Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4(12):915-25
  • Lai JF, Kao SC, Jiang ST, et al. Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells. J Biol Chem 2000;275(11):7474-80
  • Ridley AJ, Comoglio PM, Hall A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol 1995;15(2):1110-22
  • Hartmann G, Weidner KM, Schwarz H, Birchmeier W. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase Met requires intracellular action of Ras. J Biol Chem 1994;269(35):21936-9
  • She H, Rockow S, Tang J, et al. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol Biol Cell 1997;8(9):1709-21
  • Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006;117(4):725-38
  • Aspenstrom P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol 1996;6(1):70-5
  • Scaplehorn N, Holmstrom A, Moreau V, et al. Grb2 and Nck act cooperatively to promote actin-based motility of Vaccinia virus. Curr Biol 2002;12(9):740-5
  • Carlier MF, Le Clainche C, Wiesner S, Pantaloni D. Actin-based motility: from molecules to movement. Bioessays 2003;25(4):336-45
  • Higgs HN, Pollard TD. Regulation of actin filament network formation through Arp2/3 complex: activation by a diverse array of proteins. Ann Rev Biochem 2001;70(1):649-76
  • Carlier MF, Nioche P, Broutin-L'hermite I, et al. GRB2 links signaling to actin assembly by enhancing interaction of neural Wiskott-Aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex. J Biol Chem 2000;275(29):21946-52
  • Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6(6):459-71
  • Manser E, Leung T, Salihuddin H, et al. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994;367(6458):40-6
  • Puto LA, Pestonjamasp K, King CC, Bokoch GM. p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling. J Biol Chem 2003;278(11):9388-93
  • Spinardi L, Marchisio PC. Podosomes as smart regulators of cellular adhesion. Eur J Cell Biol 2006;85(3-4):191-4
  • Spinardi L, Rietdorf J, Nitsch L, et al. A dynamic podosome-like structure of epithelial cells. Exp Cell Res 2004;295(2):360-74
  • Wiederhold T, Lee MF, James M, et al. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2. Oncogene 2004;23(54):8815-25
  • Crostella L, Lidder S, Williams R, Skouteris GG. Hepatocyte growth factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner. Oncogene 2001;20(28):3735-45
  • Martinez-Quiles N, Ho HYH, Kirschner MW, et al. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 2004;24(12):5269-80
  • Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006;23(2):97-105
  • Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007;67(9):4227-35
  • McManus MJ, Boerner JL, Danielsen AJ, et al. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex. J Biol Chem 2000;275(45):35328-34
  • Sahni M, Zhou XM, Bakiri L, et al. Identification of a novel 135-kDa Grb2-binding protein in osteoclasts. J Biol Chem 1996;271(51):33141-7
  • Lim RWL, Halpain S. Regulated association of microtubule-associated protein 2 (MAP2) with Src and Grb2: evidence for MAP2 as a scaffolding protein. J Biol Chem 2000;275(27):20578-87
  • Liu YF, Deth RC, Devys D. SH3 domain-dependent association of Huntingtin with epidermal growth factor receptor signaling complexes. J Biol Chem 1997;272(13):8121-4
  • Kroll J, Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 1997;272(51):32521-7
  • Fournier E, Blaikie P, Rosnet O, et al. Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling. Oncogene 1999;18(2):507-14
  • Soriano JV, Liu N, Gao Y, et al. Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain binding antagonists. Mol Cancer Ther 2004;3(10):1289-99
  • Shono T, Kanetake H, Kanda S. The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells. Exp Cell Res 2001;264(2):275-83
  • Stoletov KV, Ratcliffe KE, Terman BI. Fibroblast growth factor receptor substrate 2 participates in vascular endothelial growth factor-induced signaling. FASEB J 2002;16(10):1283-5
  • Hiscox S, Jiang WG. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun 1997;233(1):1-5
  • Kawakami-Kimura N, Narita T, Ohmori K, et al. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br J Cancer 1997;75(1):47-53
  • Rosen EM, Lamszus K, Laterra J, et al. HGF/SF in angiogenesis. CIBA Found Symp 1997;(212):215-29
  • Rosario M, Birchmeier W. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol 2003;13(6):328-35
  • Mitra SK, Mikolon D, Molina JE, et al. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 2006;25(44):5969-84
  • Seko Y, Takahashi N, Sabe H, et al. Hypoxia induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 1999;262(1):290-6
  • Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998;50(2):197-263
  • Brenner B, Gulbins E, Schlottmann K, et al. L-Selectin activates the Ras pathway via the tyrosine kinase p56lck. Proc Natl Acad Sci USA 1996;93(26):15376-81
  • Witz IP. The involvement of selectins and their ligands in tumor-progression. Immunol Lett 2006;104(1-2):89-93
  • Barthel SR, Gavino JD, Descheny L, Dimitroff CJ. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 2007;11(11):1473-91
  • Qian F, Hanahan D, Weissman IL. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci USA 2001;98(7):3976-81
  • Di Fulvio M, Henkels KM, Gomez-Cambronero J. Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesis. Biochem Biophys Res Commun 2007;357(3):737-42
  • Huang F, Sorkin A. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 2005;16(3):1268-81
  • Tari AM, Arlinghaus R, Lopez-Berestein G. Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells. Biochem Biophys Res Commun 1997;235(2):383-8
  • Tari AM, Hung MC, Li K, Lopez-Berestein G. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene 1999;18(6):1325-32
  • Machida K, Mayer BJ. The SH2 domain: versatile signaling module and pharmaceutical target. Biochim Biophys Acta (BBA) – Proteins Proteomics 2005;1747(1):1-25
  • Kim HK, Nam JY, Han MY, et al. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in b104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells. FEBS Lett 1999;453(1-2):174-8
  • Kim HK, Jeong MJ, Kong MY, et al. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice. Life Sci 2005;78(3):321-8
  • Kim HK, Kong MY, Jeong MJ, et al. Investigation of cell cycle arrest effects of actinomycin D at G1 phase using proteomic methods in B104-1-1 cells. Int J Biochem Cell Biol 2005;37(9):1921-9
  • Nam JY, Kim HK, Kwon JY, et al. 8-O-methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor. J Nat Prod 2000;63(9):1303-5
  • Garcia-Echeverria C. Antagonists of the homology 2 (SH2) domains of Grb2, Src, Lcand ZAP-70. Curr Med Chem 2001;8(13):1589-604
  • Burke J. Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents. Int J Pept Res Ther 2006;12(1):33-48
  • Kessels HWHG, Ward AC, Schumacher TNM. Specificity and affinity motifs for Grb2 SH2-ligand interactions. Proc Natl Acad Sci USA 2002;99(13):8524-9
  • Burke J, Smyth MS, Otaka A, et al. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. Biochemistry 1994;6490-4
  • Yao ZJ, King RC, Cao T, et al. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. J Med Chem 1999;42(1):25-35
  • Burke TR, Lee K. Phosphotyrosyl mimetics in the development of signal transduction inhibitors. Acc Chem Res 2003;36(6):426-33
  • Liu WQ, Vidal M, Olszowy C, et al. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs. J Med Chem 2004;47(5):1223-33
  • Song YL, Peach ML, Roller PP, et al. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3′-substituted tyrosine derivatives. J Med Chem 2006;49(5):1585-96
  • Gay B, Suarez S, Caravatti G, et al. Selective Grb2 SH2 inhibitors as anti-Ras therapy. Int J Cancer 1999;83(2):235-41
  • Schoepfer J, Gay B, Caravatti G, et al. Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain. Bioorg Med Chem Lett 1998;8(20):2865-70
  • Caravatti G, Rahuel J, Brigitte G, Furet P. Structure-based design of a non-peptidic antagonist of the SH2 domain of Grb2. Bioorg Med Chem Lett 1999;9(14):1973-8
  • Cailliau K, Browaeys-Poly E, Broutin-L'hermite I, et al. Grb2 promotes reinitiation of meiosis in Xenopus oocytes. Cell Signal 2001;13(1):51-5
  • Zhang T, Ma J, Cao X. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Biochem J 2003;376(2):457-64
  • Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature 1988;332(6161):272-5
  • Stahl ML, Ferenz CR, Kelleher KL, et al. Sequence similarity of phospholipase C with the non-catalytic region of src. Nature 1988;332(6161):269-72
  • Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 2000;14(2):231-41
  • Mayer BJ. SH3 domains: complexity in moderation. J Cell Sci 2001;114(7):1253-63
  • Berry DM, Nash P, Liu SKW, et al. A high-affinity Arg-X-X-Lys SH3 binding motif confers specificity for the interaction between Gads and SLP-76 in T cell signaling. Curr Biol 2002;12(15):1336-41
  • Viguera AR, Arrondo JLR, Musacchio A, et al. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 1994;33(36):10925-33
  • Feller SM, Lewitzky M. Potential disease targets for drugs that disrupt protein – Protein interactions of Grb2 and Crk family adaptors. Curr Pharm Des 2006;12(5):529-48
  • Harkiolaki M, Lewitzky M, Gilbert RJC, et al. Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76. EMBO J 2003;22(11):2571-82
  • Ferguson MR, Fan X, Mukherjee M, et al. Directed discovery of bivalent peptide ligands to an SH3 domain. Protein Sci 2004;13(3):626-32
  • Nguyen JT, Turck CW, Cohen FE, et al. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science 1998;282(5396):2088-92
  • Kardinal C, Konkol B, Schulz A, et al. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients. FASEB J 2000;14(11):1529-38
  • Kardinal C, Konkol B, Lin H, et al. Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes. Blood 2001;98(6):1773-81
  • Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia. Leuk Lymphoma 2003;44(3):411-27
  • Cussac D, Vidal M, Leprince C, et al. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J 1999;13(1):31-8
  • Gril B, Vidal M, Assayag F, et al. Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. Int J Cancer 2007;121(2):407-15
  • Vidal M, Liu WQ, Lenoir C, et al. Design of peptoid analogue dimers and measure of their affinity for Grb2 SH3 domains. Biochemistry 2004;43(23):7336-44
  • Oneyama C, Nakano H, Sharma SV. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug. Oncogene 2002;21(13):2037-50
  • Kaplan KB, Swedlow JR, Morgan DO, Varmus HE. c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev 1995;9(12):1505-17
  • Shi ZD, Karki RG, Oishi S, et al. Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic. Bioorg Med Chem Lett 2005;15(5):1385-8
  • Shi ZD, Liu H, Zhang M, et al. Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity. Bioorg Med Chem 2005;13(13):4200-8
  • Koretzky GA. The role of Grb2-associated proteins in T-cell activation. Immunol Today 1997;18(8):401-6
  • Kuwai T, Nakamura T, Sasaki T, et al. Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy. Clin Exp Metastasis 2008;25(4):477-89

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.